Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Ryanodex discontinued?When does the patnet for dabigatran expire in the uk?What are vascepa's age restrictions for patient aid?In what ways does iron alter lipitor's impact on nutrient absorption?How did apotex address the fda's concerns over ruxolitinib's clinical trials?
See the DrugPatentWatch profile for keytruda
Pembrolizumab (Keytruda) received its first FDA approval in 2014. [1]
The initial FDA approval for pembrolizumab was tied to treatment of certain cancers, marking the start of Keytruda’s FDA approval timeline in 2014. [1] Sources: [1] https://www.drugpatentwatch.com/patent/Keytruda/US-9758418
Other Questions About Keytruda :